75-LB: CT-388, A novel once-weekly dual GLP-1 and GIP receptor modulator, is safe, well-tolerated, and produces more than 8% weight loss in four weeks in overweight and obese adults
HOSSAIN, Editor (2021) Al-Yousef, A., et al.: Predicting treatment outcome of spinal musculoskeletal pain using artificial neural networks: A pilot study
People have to know when they buy it online that these are for animal research, or for research studies, and they may not be getting the real thing, Aziz warned
Proteins were on-bead digested overnight in a solution containing LysC and trypsin at 37 C
How do GLP-1 drugs affect addiction
Proteome changes upon in ovo stimulation with lactobacillus synbiotic in chicken liver